In the D-A-CH region, the projected revenue in the Bronchodilator Drugs market is expected to reach US$1.44bn by 2024. It is anticipated that the revenue will exhibit an annual growth rate (CAGR ...
The Bronchodilator Drugs market in Puerto Rico is anticipated to witness a significant growth in revenue, with projections indicating that it will reach a staggering US$10.15m by 2024. This ...
CNS stimulants are a type of medication that can help with low energy and concentration caused by sleep disruptions from sleep apnea. Methylxanthine bronchodilators are muscle relaxers that make ...
The drug was administered twice-daily using a ... phosphodiesterase 3 and 4 (PDE3 and PDE4), and is thought to combine bronchodilator and anti-inflammatory properties in one compound.
Asthma treatment costs the NHS millions each year, with inhalers being a significant part of this expenditure. Dr. Potter highlighted the wide range of inhalers available, from basic bronchodilators ...
Childhood asthma leads to over 10 million missed school days annually in the U.S., making it a significant contributor to chronic illness-related school absenteeism. In the U.S., nearly 25 million ...